12 Health Care Stocks Moving In Friday's Intraday Session
I'm LongbridgeAI, I can summarize articles.In Friday's trading session, Tandem Diabetes Care (TNDM) saw a significant gain of 35% to $25, following its Q4 earnings report, while Bristol-Myers Squibb's Celgene CVR (CELGR) rose 22.21% to $0.11. Other notable gainers included Cardio Diagnostics (CDIO) up 19.64%, enVVeno Medical (NVNO) up 18.11%, and Nasus Pharma (NSRX) up 18%. Conversely, GRAIL (GRAL) experienced a sharp decline of 47.8% to $53.02, with Dermata Therapeutics (DRMA) down 25.86%, and BioRestorative Therapies (BRTX) down 15.75%.
Gainers
- Tandem Diabetes Care (NASDAQ:TNDM) stock increased by 35.0% to $25.0 during Friday's regular session. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q4 earnings report came out yesterday.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 22.21% to $0.11.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 19.64% to $2.68. The market value of their outstanding shares is at $4.0 million.
- enVVeno Medical (NASDAQ:NVNO) shares increased by 18.11% to $11.8. The market value of their outstanding shares is at $6.5 million.
- Nasus Pharma (AMEX:NSRX) shares moved upwards by 18.0% to $5.9. The company's market cap stands at $58.7 million.
- Sensei Biotherapeutics (NASDAQ:SNSE) stock increased by 16.86% to $31.81. The company's market cap stands at $34.3 million.
Losers
- GRAIL (NASDAQ:GRAL) stock fell 47.8% to $53.02 during Friday's regular session. The market value of their outstanding shares is at $3.9 billion. As per the news, the Q4 earnings report came out yesterday.
- Dermata Therapeutics (NASDAQ:DRMA) shares decreased by 25.86% to $1.43. The company's market cap stands at $5.4 million.
- BioRestorative Therapies (NASDAQ:BRTX) shares declined by 15.75% to $0.23. The market value of their outstanding shares is at $6.2 million.
- Candel Therapeutics (NASDAQ:CADL) shares declined by 14.54% to $5.08. The market value of their outstanding shares is at $326.6 million.
- Harmony Biosciences Hldgs (NASDAQ:HRMY) shares fell 13.67% to $29.69. The company's market cap stands at $1.9 billion.
- Regencell Bioscience (NASDAQ:RGC) shares decreased by 12.3% to $29.34. The company's market cap stands at $16.5 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.